319 related articles for article (PubMed ID: 27355215)
1. Conidial germination in Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans: influence of growth conditions and antifungal susceptibility profiles.
Mello TP; Aor AC; Oliveira SS; Branquinha MH; Santos AL
Mem Inst Oswaldo Cruz; 2016 Jun; 0(7):0. PubMed ID: 27355215
[TBL] [Abstract][Full Text] [Related]
2. Scedosporium apiospermum, Scedosporium aurantiacum, Scedosporium minutisporum and Lomentospora prolificans: a comparative study of surface molecules produced by conidial and germinated conidial cells.
Mello TP; Aor AC; Gonçalves DS; Seabra SH; Branquinha MH; Santos ALSD
Mem Inst Oswaldo Cruz; 2018; 113(6):e180102. PubMed ID: 29924142
[TBL] [Abstract][Full Text] [Related]
3. N-Chlorotaurine Exhibits Fungicidal Activity against Therapy-Refractory Scedosporium Species and Lomentospora prolificans.
Lackner M; Binder U; Reindl M; Gönül B; Fankhauser H; Mair C; Nagl M
Antimicrob Agents Chemother; 2015 Oct; 59(10):6454-62. PubMed ID: 26239996
[TBL] [Abstract][Full Text] [Related]
4. Assessment of biofilm formation by Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans.
Mello TP; Aor AC; Gonçalves DS; Seabra SH; Branquinha MH; Santos AL
Biofouling; 2016 Aug; 32(7):737-49. PubMed ID: 27309801
[TBL] [Abstract][Full Text] [Related]
5. Insights into the interaction of Scedosporium apiospermum, Scedosporium aurantiacum, Scedosporium minutisporum, and Lomentospora prolificans with lung epithelial cells.
de Mello TP; Aor AC; Branquinha MH; Dos Santos ALS
Braz J Microbiol; 2020 Jun; 51(2):427-436. PubMed ID: 31736016
[TBL] [Abstract][Full Text] [Related]
6. Decoding the antifungal resistance mechanisms in biofilms of emerging, ubiquitous and multidrug-resistant species belonging to the Scedosporium/Lomentospora genera.
Mello TP; Oliveira SSC; Branquinha MH; Santos ALS
Med Mycol; 2022 Jun; 60(6):. PubMed ID: 35641191
[TBL] [Abstract][Full Text] [Related]
7. Impact of biofilm formation and azoles' susceptibility in Scedosporium/Lomentospora species using an in vitro model that mimics the cystic fibrosis patients' airway environment.
Mello TP; Lackner M; Branquinha MH; Santos ALS
J Cyst Fibros; 2021 Mar; 20(2):303-309. PubMed ID: 33334714
[TBL] [Abstract][Full Text] [Related]
8. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
Wiederhold NP; Law D; Birch M
J Antimicrob Chemother; 2017 Jul; 72(7):1977-1980. PubMed ID: 28333310
[TBL] [Abstract][Full Text] [Related]
9. Surface properties, adhesion and biofilm formation on different surfaces by
Mello TP; Oliveira SSC; Frasés S; Branquinha MH; Santos ALS
Biofouling; 2018 Aug; 34(7):800-814. PubMed ID: 30354689
[TBL] [Abstract][Full Text] [Related]
10. Cell dispersion during biofilm formation by
Mello TP; Barcellos IC; Branquinha MH; Santos ALS
Curr Res Microb Sci; 2023; 4():100191. PubMed ID: 37229517
[TBL] [Abstract][Full Text] [Related]
11. GROWTH-INHIBITORY EFFECTS OF FARNESOL AGAINST SCEDOSPORIUM BOYDII AND LOMENTOSPORA PROLIFICANS.
Pumeesat P; Wongsuk T; Muangkaew W; Luplertlop N
Southeast Asian J Trop Med Public Health; 2017 Jan; 48(1):170-8. PubMed ID: 29644833
[TBL] [Abstract][Full Text] [Related]
12. Pandemic Response Box® library as a source of antifungal drugs against Scedosporium and Lomentospora species.
Rollin-Pinheiro R; Xisto MIDDS; de Castro-Almeida Y; Rochetti VP; Borba-Santos LP; Fontes YDS; Ferreira-Pereira A; Rozental S; Barreto-Bergter E
PLoS One; 2023; 18(2):e0280964. PubMed ID: 36735743
[TBL] [Abstract][Full Text] [Related]
13. Metallopeptidase inhibitors arrest vital biological processes in the fungal pathogen Scedosporium apiospermum.
Silva BA; Souza-Gonçalves AL; Pinto MR; Barreto-Bergter E; Santos AL
Mycoses; 2011 Mar; 54(2):105-12. PubMed ID: 19702620
[TBL] [Abstract][Full Text] [Related]
14. Biofilms formed by
Mello TP; Branquinha MH; Santos ALS
Biofouling; 2020 Mar; 36(3):308-318. PubMed ID: 32401558
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of olorofim against clinical isolates of Scedosporium species and Lomentospora prolificans using EUCAST and CLSI methodologies.
Rivero-Menendez O; Cuenca-Estrella M; Alastruey-Izquierdo A
J Antimicrob Chemother; 2020 Dec; 75(12):3582-3585. PubMed ID: 32856079
[TBL] [Abstract][Full Text] [Related]
16. Repurposing of auranofin and honokiol as antifungals against
Yaakoub H; Staerck C; Mina S; Godon C; Fleury M; Bouchara JP; Calenda A
Virulence; 2021 Dec; 12(1):1076-1090. PubMed ID: 33825667
[TBL] [Abstract][Full Text] [Related]
17. Effects of Photodynamic Therapy on the Growth and Antifungal Susceptibility of Scedosporium and Lomentospora spp.
Lu Q; Sun Y; Tian D; Xiang S; Gao L
Mycopathologia; 2017 Dec; 182(11-12):1037-1043. PubMed ID: 28836110
[TBL] [Abstract][Full Text] [Related]
18. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
Lewis RE; Wiederhold NP; Klepser ME
Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium.
Sedlacek L; Graf B; Schwarz C; Albert F; Peter S; Würstl B; Wagner S; Klotz M; Becker A; Haase G; Laniado G; Kahl B; Suerbaum S; Seibold M; Tintelnot K
J Cyst Fibros; 2015 Mar; 14(2):237-41. PubMed ID: 25595044
[TBL] [Abstract][Full Text] [Related]
20. Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.
Gil-Lamaignere C; Roilides E; Mosquera J; Maloukou A; Walsh TJ
Antimicrob Agents Chemother; 2002 Jul; 46(7):2234-7. PubMed ID: 12069979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
